RNA Therapeutics Company SiSaf to Present at Upcoming Conferences
SiSaf Announces Michael J. Econs MD, World-leading Expert in Metabolic Bone Disease, as Clinical Advisor
SiSaf exercises its option under licencing agreement on gene therapy for rare bone disease
SiSaf Ltd utilizes Intoolab’s Tzager AI Platform
Next Page »
Find out more.
Okay, thank you